GEODE CAPITAL MANAGEMENT, LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1214717 BOSTON, MA

Position in FTRE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$44,313,815

+$22,021,603 QoQ

Shares Held

2,546,771

+7.6% QoQ

Ownership

2.68%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. FTRE ranks #90 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$44,313,815	2,546,771	+7.6%	Shares	Defined	2026-08-12
2026-03-31	$22,292,212	2,366,477	+3.8%	Shares	Defined	2026-05-15
2025-12-31	$39,311,611	2,278,934	+9.4%	Shares	Defined	2026-02-09
2025-09-30	$17,531,913	2,082,175	-4.1%	Shares	Defined	2025-11-12
2025-06-30	$10,726,962	2,171,450	+37.2%	Shares	Defined	2025-08-08
2025-03-31	$11,946,401	1,582,305	+5.9%	Shares	Defined	2025-05-13
2024-12-31	$27,872,443	1,494,501	-0.5%	Shares	Defined	2025-02-12
2024-09-30	$30,050,920	1,502,546	+1.4%	Shares	Defined	2024-11-12
2024-06-30	$34,583,367	1,481,721	+6.9%	Shares	Defined	2024-08-09
2024-03-31	$55,625,409	1,385,785	+3.4%	Shares	Defined	2024-05-13
2023-12-31	$46,764,045	1,339,944	+4.2%	Shares	Defined	2024-02-13
2023-09-30	$36,767,254	1,286,018	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.